BSE filing, NSE: SOFTRAK. Summary written from the filing by ALFA Finder's alert engine.
Softrak Venture Investment Ltd: key numbers
- Share price
- ₹1.44
- Market cap
- ₹64.91 Cr
- Revenue (annual)
- ₹1.06 Cr
- Net profit (annual)
- ₹0.16 Cr
- P/E (TTM)
- 307.7×Sector 19.7×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Softrak Venture Investment Ltd
All →Softrak Venture Investment Other Announcement
Softrak Venture Investment Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Softrak Venture Investment Annual General Meeting
Shareholders approved a special resolution authorizing the monetization and disposal of the company's non-operational barren land asset in Gujarat during the 33rd AGM.
Softrak Venture Investment Annual General Meeting
Softrak Venture Investment Ltd announced the voting results for its 33rd Annual General Meeting held on September 25, 2026. All four resolutions were passed by shareholders.
Softrak Venture Investment Annual General Meeting
Softrak Venture Investment issued an addendum to its 33rd AGM notice, seeking shareholder approval for the potential sale of its non-operational land asset in Gujarat.
Softrak Venture Investment Board Meeting Outcome
Softrak's board approved selling its non-operational Gujarat land asset, seeking shareholder approval at the AGM. No price is set as the buyer and valuation remain pending.
Softrak Venture Investment Annual General Meeting
Softrak Venture Investment has issued the notice for its 33rd AGM on 25-Sep-2026. The agenda covers adoption of FY26 financials, MD re-appointment, a Rs 0.005/share dividend, and a new independent director appointment.
Other board meeting date announcements
All →Natco Pharma Board Meeting Date
Natco Pharma will hold a board meeting on 13 November 2026 to consider unaudited quarterly results and an interim dividend. Trading window closed until 15 November 2026.
Faze Three Board Meeting Date
Faze Three Ltd intimated a board meeting on November 3, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closure is also noted.
Real Eco-Energy Board Meeting Date
Real Eco-Energy schedules a board meeting on 04 November 2026 for unaudited quarterly results. The trading window stays closed until results are declared.
Arvaya Healthcare Board Meeting Date
Arvaya Healthcare schedules a 4 November 2026 board meeting on rights issue, draft letter of offer and related party transactions. Agenda items remain proposed only.
Prism Johnson Board Meeting Date
Prism Johnson intimated a board meeting on 6 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The meeting has not yet been held.
Bharat Textiles & Proofing Industries Board Meeting Date
Bharat Textiles & Proofing Industries will hold a board meeting on 05 November 2026 to consider unaudited standalone quarterly and half-year results. Results await approval.